Published in:

01-10-2011 | Original Research

Long-term safety and efficacy of the recombinant human growth hormone omnitrope® in the treatment of Spanish growth hormone deficient children: Results of a phase III study

Authors: J. López-Siguero, V. Borrás Pérez, S. Balser, J. Khan-Boluki

Published in: Advances in Therapy | Issue 10/2011